NGS‐MRD negativity in post‐HSCT ALL spares unnecessary therapeutic interventions triggered by borderline qPCR results without an increase in relapse risk

Abstract Monitoring of minimal residual disease (MRD) after hematopoietic stem cell transplantation (HSCT) in patients with acute lymphoblastic leukemia (ALL) is vital for timely therapeutic intervention planning. However, interpreting low‐positive results from the current standard method, quantitat...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Krystof Seferna, Michael Svaton, Andrea Rennerova, Aneta Skotnicova, Leona Reznickova, Tatana Valova, Petr Sedlacek, Petr Riha, Renata Formankova, Petra Keslova, Lucie Sramkova, Jan Stary, Jan Zuna, Alexandra Kolenova, Cyril Salek, Jan Trka, Eva Fronkova
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Wiley 2025-04-01
Reeks:	HemaSphere
Online toegang:	https://doi.org/10.1002/hem3.70124
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!